The complete blood count and leukocyte differential count. An approach to their rational application

Insights

Complete blood count (CBC) and leukocyte differential counts are generally not useful for screening healthy individuals. Limited use cases exist for specific populations or when clinical suspicion is high, guiding targeted diagnostic approaches.

Area of Science:

  • Clinical Pathology
  • Diagnostic Laboratory Medicine
  • Evidence-Based Medicine

Background:

  • Complete blood count (CBC) and leukocyte differential counts are common laboratory tests.
  • Their utility in routine screening and diagnosis requires critical evaluation.

Purpose of the Study:

  • To assess the value of CBC and leukocyte differential counts in various clinical settings.
  • To provide evidence-based recommendations for appropriate test utilization.

Main Methods:

  • Systematic review of existing literature on CBC and leukocyte differential count utility.
  • Analysis of diagnostic yield in asymptomatic individuals, specific populations, and hospitalized patients.

Main Results:

  • CBC and leukocyte differential counts lack value for general population screening.
  • Potential utility identified for infants, elderly, pregnant women, and immigrants with nutritional concerns.
  • Limited value in hospitalized patients unless specific abnormalities or major blood loss are anticipated.
  • Leukocyte differential count often unnecessary for confirming infection when leukocytosis is present.

Conclusions:

  • Routine screening with CBC and leukocyte differential counts is not recommended for asymptomatic individuals.
  • Test utilization should be guided by clinical suspicion and specific patient populations.
  • Repeat testing should be judiciously applied based on clinical course and potential impact on decision-making.